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Choline is an essential component in acetylcholine
biosynthesis, and is involved in cell signaling. It is
unable to permeate the cell membrane and requires a
transporter to enter the cell. Neurons that synthesize
acetylcholine take up choline by a recently cloned
high-af®nity choline transporter (choline transporter
1) that is Na+-dependent and can be blocked by
hemicholinium-3. The aim of this study was to deter-
mine the expression and to analyze the distribution of
choline transporter 1 in human and rat skin. The
mRNA for choline transporter 1 was detected in rat
and human skin and in the human keratinocyte cell
line HaCaT. A polyclonal anti-serum was developed
against the N-terminal region of the human and rat
protein. In rat and human skin, choline transporter 1
immunoreactivity was present in nerve ®bers. In
addition, keratinocytes, HaCaT cells and cells of the
internal root sheath of the hair follicle contained
choline transporter 1 immunoreactivity. The labeling
patterns of noncon¯uent vs con¯uent cultured cells
and the distribution of choline transporter 1 along the
epidermal layer suggest an association of choline
transporter 1 with keratinocyte differentiation. In
conclusion, this study shows the presence of the high-
af®nity choline transporter choline transporter 1 in
nerve ®bers and epithelial cells in the human and rat
skin supporting the pivotal role of this transporter in
both the neuronal and non-neuronal cholinergic sys-
tem of the skin. Key words: HaCaT cells/hair follicle/
keratinocytes/sweat glands/vasculature. J invest Dermatol
119:943±948, 2002
T
he skin contains elements of the neuronal and a non-
neuronal cholinergic system: eccrine sweat glands
receive cholinergic nerve ®bers (Landis, 1999), and
the keratinocytes of the epidermis synthesize and
release acetylcholine (ACh) (Grando et al, 1993a, b,
1995; Klapproth et al, 1997). Additional non-neuronal sources of
ACh are the vascular endothelium and/or leukocytes (Milner et al,
1989; Misery 1998; Fujii and Kawashima, 2001; Kirkpatrick et al,
2001). The uptake of choline is the rate-limiting step in ACh
synthesis (Okuda and Haga, 2000). Choline is an essential
component in ACh biosynthesis, and it is also involved in cell
signaling. It is unable to permeate the cell membrane and requires a
transporter to enter the cell. Neurons that synthesize ACh take up
choline by a high-af®nity choline transporter (CHT1) that is Na+-
dependent and can be blocked by hemicholinium-3 (Swann and
Hewitt, 1988; Okuda and Haga, 2000). Recently, the human and
rat neuronal CHT1 were cloned (Okuda and Haga, 2000; Okuda
et al, 2000). It has been proposed that CHT1 is unique to
cholinergic neurons as the mRNA for CHT1 was detected by
northern blotting and in-situ hybridization in different areas of the
rat brain but not in non-neuronal tissues (Okuda et al, 2000). In this
study we aimed to determine the localization of CHT1 in the skin,
in particular as to whether non-neuronal cholinergic cells also
express the CHT1 protein. To investigate the distribution of
CHT1 protein in human and rat skin, a polyclonal anti-serum was
developed against the N-terminal region (amino acid residues 29±
40) of the human and rat sequence. In support of the
immunohistochemical ®ndings reverse transcription±polymerase
chain reaction (reverse transcription±PCR) analysis of skin and the
human keratinocyte cell line, HaCaT, was performed.
MATERIALS AND METHODS
Reverse transcription±PCR For reverse transcription±PCR, human
and rat skin were quick-frozen in RNazol (WAK-Chemie, Bad-
Homburg, Germany), homogenized using a turrax, and the total RNA
was isolated using the RNazol reagent technique according to the
recommended protocol. The total RNA from HaCaT cells was isolated
using the Qiagen-kit (Qiagen, Heiden, Germany) according to the
recommended protocol. The contaminating DNA was removed by
DNase (1 U per mg total RNA; Gibco-BRL, Life Technologies,
Karlsruhe, Germany) in the presence of 20 mM Tris±HCl (pH 8.4), 2 mM
MgCl2, and 50 mM KCl for 15 min at 25°C. Equal amounts of the RNA
were reverse transcribed in the presence of 3 mM MgCl2, 75 mM KCl,
50 mM Tris±HCl (pH 8.3), 10 mM dithiothreitol, 0.5 mM deoxyribo-
nucleoside triphosphate (Gibco-BRL) and 25 mM oligo(dT) (MWG
Biotech, Ebersberg, Germany), with 200 University of Superscript RNase
H± Reverse transcriptase (Gibco-BRL) for 50 min at 42°C. For the PCR
reaction 5 ml buffer II, 5 ml MgCl2, 1 ml deoxyribonucleoside
triphosphate (10 mM each), 0.5 ml (2 U) AmpliTaq Gold polymerase (all
reagents from Perkin Elmer) and 1 ml of each primer (20 mM, rat, forward:
CAAGACCAAGGAGGAAGCAG reverse: GCAAACATGGAACT-
TGCTGA GenBank accession number BAA90484; human, forward:
ATCCCAGCCATACTCATTGG reverse: CAGAAACTGCACCA-
AGACCA GenBank accession number AB04399, MWG Biotech) were
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mixed. Cycling conditions for time release hot start PCR were 12 min at
95°C, 45 cycles of 20 s at 94°C, 20 s at 60°C and 20 s at 72°C followed
by 7 min at 72°C. Control reactions for reverse transcription±PCR,
including the absence of the reverse transcription±reaction before PCR
and the absence of template showed no ampli®cation products.
Preparation of the CHT1 anti-sera Polyclonal guinea-pig and rabbit
anti-sera were raised against the synthetic peptide TKNSGNAEERSE
that corresponds to the amino acid residues 28±40 of rat CHT1
(GenBank accession number AB030947) and to the AS 29±40 of human
CHT1(accession number AAG25940) (Pineda Anti-koÈrper-Service,
Berlin, Germany) (Lips et al, 2002).
Immunohistochemistry Specimens of human skin were obtained
from surgery. Hairy skin of the head and glabrous skin of the inguinal
region were dissected. Specimens of glabrous and hairy skin of rat hind
paws were obtained from Wistar rats of either sex that were killed by
chloroform inhalation. The specimens were immersed in Zamboni's
®xative (Zamboni and deMartino, 1967) and then washed repeatedly in
0.1 M phosphate buffer, cryoprotected in the same buffer with 18%
sucrose added, snap frozen in liquid nitrogen and stored at ± 20°C until
processed for immunostaining. They were sectioned at a thickness of
10 mm with a cryostat (Jung Frigocut 1900 E, Leica, Bensheim,
Germany). Sections were covered for 1 h with blocking medium
(phosphate-buffered saline containing 10% normal porcine serum, 0.1%
bovine serum albumin, and 0.5% Tween 20) followed by incubation
with the primary anti-sera (CHT1, guinea-pig anti-serum 1 : 1000;
CHT1, rabbit anti-serum, 1 : 1600; VAChT goat anti-serum, 1 : 800,
Biotrend, KoÈln, Germany). Then the sections were washed in
phosphate-buffered saline and covered for 1 h with secondary reagents.
The sections were covered with either a ¯uorescein isothiocyanate-
conjugated mouse anti-goat IgG (1 : 200, Sigma, Deisenhofen,
Germany) or with Texas Red-conjugated donkey anti-guinea pig IgG
(1 : 100, Dianova, Hamburg, Germany) or a Cy-3-conjugated donkey
anti-rabbit immunoglobulin anti-serum (1 : 1000, Dianova). For double-
labeling immuno¯uorescence the sections were incubated overnight with
CHT1 and VAChT anti-sera, washed and covered with ¯uorescein
isothiocyanate-conjugated mouse anti-goat IgG in combination with
either Texas Red-conjugated donkey anti-guinea-pig IgG or a Cy-3-
conjugated donkey anti-rabbit immunoglobulin anti-serum.
HaCaT cells (Boukamp et al, 1988) were cultured to con¯uence in
RPMI 1640 tissue culture medium (Invitrogen, Karlsruhe, Germany)
supplemented with 10% heat inactivated fetal bovine serum and 1%
penicillin/streptomycin/amphotericin at 37°C under normoxic condi-
tions (5% CO2, 95% air). For the experiments, the cells were detached
with 0.1% trypsin/0.05% ethylenediamine tetraacetic acid (1 : 1) and
resuspended in RPMI 1640 medium containing 10% fetal bovine serum
and 1% penicillin/streptomycin/amphotericin. Five thousand cells per
well grew in eight-well chamber slides for 2 d. After 1 d, 10±4 M of the
speci®c CHT1 inhibitor, hemicholinium-3 was added. Control cells
grew in absence of hemicholinium-3. After 2 d, cells were ®xed in
Zamboni's ®xative for 20 min followed by washing steps and incubation
with primary and secondary anti-sera as described above. After incuba-
tion with the secondary reagents, the slides were washed in phosphate-
buffered saline and coverslipped in carbonate-buffered glycerol at
pH 8.6. Preabsorption with the corresponding synthetic peptide (20±
100 mg antigen per ml diluted anti-serum) abolished immunolabeling.
The slides were evaluated by epi¯uorescence microscopy (Olympus BX
60F, Hamburg, Germany) using appropriate ®lter combinations for Cy3
(excitation ®lter 525±560 nm, barrier ®lter 570±650 nm) and ¯uorescein
isothiocyanate (excitation ®lter 460±490 nm, barrier ®lter 515±550 nm).
RESULTS
Reverse transcription±PCR In samples of human and rat skin
and rat spinal cord, PCR products of 150 bp in length could be
ampli®ed corresponding to the region 1153±1303 of the rat. A
PCR product 169 bp in length, corresponding to the region 1131±
1300 of the human CHT1 mRNA could be ampli®ed from human
skin and the human keratinocyte cell line, HaCaT (Fig 1).
Immunohistochemistry The rabbit and the guinea-pig CHT1-
anti-sera showed similar staining of nerve ®bers in rat skin (Fig 2).
Double-labeling immuno¯uorescence revealed colocalization of
CHT1 immunoreactivity and VAChT immunoreactivity in nerve
®bers at sweat glands and in motor endplates (Fig 2).
Rat skin A subpopulation of nerve ®bers in the rat skin exhibited
CHT1 immunoreactivity. Sweat glands of hairy and glabrous skin
received a dense CHT1/VAChT immunoreactivity innervation
(Fig 2). The underlying plantar skeletal muscles showed intense
CHT1/VAChT immunoreactivity in motor endplates and nerve
®bers (Fig 2). CHT1 immunoreactivity ®bers were present in small
numbers in the plexus at the epidermal±dermal junction and run
parallel to the basal lamina but immunoreactive axons could not be
observed in the epidermal layer (Fig 3). Keratinocytes of hairy and
glabrous skin showed CHT1 immunoreactivity (Fig 3). CHT1
immunoreactivity nerve ®bers were found in nerve ®ber bundles
and at larger blood vessels in the subcutis (Fig 3). CHT1
immunoreactivity nerve ®bers occurred at a nerve plexus
adjacent to the inner epithelial layer of the hair follicles (Fig 4).
Cells of the internal root sheath of the hair follicle were strongly
CHT1 immunoreactivity (Fig 5). The skin area used contained no
piloarrector muscles. Sebaceous glands were devoid of an
innervation by CHT1 immunoreactivity axons (not shown).
Human skin Nerve ®ber bundles in the dermis and subcutis
showed intense CHT1 immunoreactivity, whereas the nerve ®ber
plexus at the epidermis±dermis junction was devoid of CHT1
immunoreactivity axons. In addition, single CHT1 immuno-
reactivity nerve ®bers were found at the hair shaft, in arrector pili
muscles, and around eccrine sweat glands and blood vessels (Fig 6).
CHT1 immunoreactivity nerve ®bers innervating the sweat glands
Figure 1. Reverse transcription±PCR detected CHT1-mRNA in rat and human skin. PCR products corresponding to the rat and human
CHT1-mRNA could be obtained in rat and human skin and in human HaCaT cells. Rat brain served as a positive control. M = 100 bp marker.
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were found in close apposition to acini and ducts. (Fig 6). Larger
vessels of the deeper dermis received a perivascular innervation by
CHT1 immunoreactivity nerve ®bers (Fig 6). The vessels in the
super®cial layer at the epidermis±dermis junction showed no
innervation by CHT1 immunoreactivity axons. Immunoreactivity
for CHT1 was found in the anagen hair follicle. Cells of the
internal root sheath showed strong CHT1 immunoreactivity
Figure 4. Indirect immunolabeling of rat hairy skin
demonstrated CHT1 in nerve ®bers. CHT1 immunoreactivity nerve
®bers could be demonstrated in nerve ®bers adjacent to the inner
epithelial layer of the hair follicles (arrows in a,b). Slight auto¯uorescence
of the hair is demonstrated in c under ultraviolet illumination. Scale
bars = 20 mm.
Figure 2. Indirect immuno¯uorescence of CHT1 in the rat sweat
gland and striated muscle. The guinea-pig anti-CHT1 (a,b) and the
rabbit anti-CHT1 (a¢,b¢) anti-serum labeled nerve ®bers at eccrine sweat
glands (a,a¢) and motor endplates in plantar striated muscles (b,b¢).
Both,the ®bers at eccrine glands (c,d) and the motor endplates (e,f)
showed immunoreactivity for CHT1 and VAChT (arrows c±f). Scale
bars = 50 mm.
Figure 3. Indirect immuno¯uorescence of rat glabrous skin
showed CHT1 in nerve ®bers and keratinocytes. In the rat glabrous
skin CHT1 immunoreactivity nerve ®bers (arrow in a) occurred at the
epidermis±dermis border (a). In the deeper dermis, CHT1 immuno-
reactivity was present nerve ®ber bundles (arrowhead in c) and in
perivascular nerve ®bers (arrowhead in d). Note the nerve ®ber near the
eccrine gland duct (arrow in c). The keratinocytes of the epidermis
showed staining of the membrane (b). Epithelial cells of the eccrine ducts
exhibited strong ¯uorescence that could not be preabsorbed (c,d). Scale
bar = 20 mm.
Figure 5. Indirect immuno¯uorescence of rat hairy skin revealed
the presence of CHT1 in cells of the internal root sheath of the
hair follicle. Immunoreactivity for CHT1 was found in hair follicles in
the outer epithelial layer (a,c,d). Cells of the internal root sheath (c,d)
showed strong CHT1 immunoreactivity. The CHT1 immunoreactivity
was strongly reduced after preabsorption (Pre) with the corresponding
antigen (b). Scale bars = 20 mm.
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(Fig 7). Staining for CHT1 was also observed in keratinocytes of
the epidermal layer (Fig 8).
HaCaT cells After 2 d of culture, about two-thirds of the chamber
area were covered by a con¯uent monolayer. The keratinocytes
showed variations in size and shape. CHT1 immunolabeling of the
HaCaT cells was more intense using the rabbit anti-serum. CHT1
immunoreactivity was observed in two different patterns. Most cells
grown in a monolayer expressed strong immunoreactivity at cell±
cell contacts and a slight cytosolic CHT1 immunoreactivity. The
membranous CHT1 immunoreactivity was present only within
monolayers, whereas intense cytosolic CHT1 immunoreactivity
was found in border regions of the monolayer and in cells islets after
1 d in culture (Fig 8). The immunoreactivity of the cell membrane
increased after exposure to hemicholinium-3 for 1 d, whereas the
cytosolic CHT1 immunoreactivity decreased (Fig 8).
DISCUSSION
This study is one of the ®rst to demonstrate the localization and
distribution of the high-af®nity choline transporter, CHT1, in the
skin of humans and rat. In addition to nerve ®bers, CHT1 is present
in non-neuronal structures, i.e., keratinocytes of the epidermis and
hair shafts.
CHT1 in nerve ®bers In the CNS, CHT1 is present in
cholinergic neurons as demonstrated by detection of its mRNA by
northern blotting and in-situ hybridization in different areas of the
rat brain, and by localizing the CHT1 protein in spinal
motoneurons and in motor endplates by immunohistochemistry
(Okuda et al, 2000; Kobayashi et al, 2002; Lips et al, 2002). In the
skin, one well known cholinergically innervated tissue are eccrine
sweat glands (Ernsberger and Rohrer, 1999). Sweat glands are
Figure 7. CHT1 immunolabeling of human hair follicles. Immunoreactivity for CHT1 was found in hair follicles (a,b). Cells of Huxley's layer
(b) showed strong CHT1 immunoreactivity. The immunolabeling was strongly reduced after preabsorption (Pre) with the corresponding antigen (a).
Scale bars = 20 mm.
Figure 8. CHT1 immunolabeling of human epidermis and
cultured HaCaT cells. The epidermis of human skin (asterisk) revealed
CHT1 immunoreactivity (a) that was absent after preabsorption (b). In
monolayers of HaCaT cells strong CHT1 immunoreactivity is present at
the membrane of cell±cell contacts (c,e,f) and/or in the cytosol (c,d).
Preabsorption (Pre) with the corresponding antigen abolished
immunolabeling (d, inset). After treatment with hemicholinium-3, the
CHT1 immunoreactivity of the membrane increased (e,f). Note the
strong CHT1 immunoreactivity in the membrane of cell±cell contacts
(f). Scale bars = 50 mm.
Figure 6. Indirect immuno¯uorescence of human skin showed
CHT1 immunoreactivity nerve ®bers. In the human skin CHT1
immunoreactivity nerve ®bers (arrows in b,c,d) were present in ®ber
bundles (a), in eccrine glands (b), at piloarrector muscles (c), and at
vessels in the deeper dermis (d). Scale bar = 20 mm.
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innervated by sympathetic neurons that undergo a change in
transmitter phenotype from noradrenergic to cholinergic during
development (Landis et al, 1988; Guidry and Landis, 1998;
Fernandez-Fernandez et al, 1999). Evidence for the presence of a
high-af®nity choline uptake in eccrine glands has been provided by
the inhibition of the choline-mediated glandular stimulation by
hemicholinium-3, a speci®c blocker of CHT1 (Lamb et al, 1983).
Here, we could show the presence of CHT1 immunoreactivity in
nerve ®bers innervating the glands in the subcutis. The ®bers
exhibited colocalization of CHT1 immunoreactivity and immuno-
reactivity for VAChT. This corroborates previous immunohisto-
chemical studies that showed immunoreactivity for VAChT and
the ACh synthesizing enzyme choline acetyltransferase in nerve
®ber bundles at or surrounding the glands (Guidry and Landis,
1998; Zancanaro et al, 1999). Thus, the CHT1 immunoreactivity
axons surrounding the glandular acini in the rat paw represent the
sympathetic cholinergic sweat gland innervation.
In addition to the eccrine sweat glands, the vasculature in the
deeper dermis is densely surrounded by CHT1 immunoreactivity
nerve ®bers, whereas the vessels at the epidermis±dermis border
received no CHT1 immunoreactivity ®bers. It is not clear if these
®bers simply accompany or really innervate the vessels. To clarify if
CHT1 immunoreactivity ®bers indeed innervate deeper vessels, the
vasculature has to be examined at the ultrastructural level.
Functional studies on rat and human skin indicate the contribution
of cholinergic ®bers in the control of the skin vasculature (Low and
Westerman, 1989; Muck-Weymann et al, 1996).
Differences in the distribution of CHT1 immunoreactivity ®bers
between rat and humans were present in the nerve plexus at the
epidermis±dermis border. This plexus presumably consists of
sensory ®bers (Dux et al, 1999). So far neither choline
acetyltransferase nor VAChT protein have been described in
cutaneous sensory nerve terminals. Nonetheless, the presence of
cholinergic ®bers in this plexus cannot be excluded as Sann et al
(1995) showed choline acetyltransferase immunoreactivity in
sensory neurons of small diameter in rat lumbar dorsal root ganglia.
Therefore, subpopulations of sensory neurons might well be
capable of ACh synthesis and, hence, may require a high-af®nity
choline uptake. Similarly, CHT1 immunoreactivity nerve ®bers
occurred also in the nerve plexus termed ``follicular network A''
adjacent to the inner epithelial layer of the hair follicles, which also
primarily contains sensory ®bers (Botchkarev et al, 1998; Peters etal,
2001).
The arrector pili muscle is innervated by nerve ®bers that
originate from sympathetic ganglia. In the guinea-pig and the rat,
practically all of these ®bers are immunoreactive for the rate-
limiting enzyme in norepinephrine synthesis, tyrosine hydroxylase,
and therefore these axons are noradrenergic (Gibbins, 1991;
Roth and Kummer, 1994; Bergner et al, 2000); however, ®bers
innervating the human piloarrector muscle showed CHT1
immunoreactivity that has been demonstrated in cholinergic ®bers
(Okuda et al, 2000; Lips et al, 2002).
CHT1 in non-neuronal cells The mRNA for CHT1 was
detected in human and rat skin specimens and in HaCaT cells. In
the skin neurons do not account for the content of CHT1-mRNA,
as mRNA is generally restricted to neuronal perikarya and proximal
dendrites, but are excluded from axonal processes. The perikarya of
neurons innervating the skin are located in sympathetic chain and
sensory ganglia at the vertebral column or the base of the skull.
Therefore, the detection of CHT1-mRNA in the skin is due to the
expression of CHT1 in non-neuronal cells. There are several lines
of evidence that these non-neuronal cells are represented by the
keratinocytes. Both CHT1-mRNA and CHT1-protein were
identi®ed in the keratinocyte cell line, HaCaT, by reverse
transcription±PCR and immunohistochemistry, respectively, and
CHT1 immunoreactivity was also observed in keratinocytes in situ.
Thus, the present data are in favor of a choline recycling pathway in
keratinocytes, as it has previously been shown that they synthesize,
release, and cleave ACh (Grando et al, 1993a, b; Grando, 1997;
Ndoye et al, 1998; Nguyen et al, 2001). The increase of CHT1
immunoreactivity observed in the membrane of HaCaT cells
treated with hemicholinium-3 suggests the potential of a dynamic
regulation of this recycling pathway similar to that observed in
cholinergic neurons where hemicholinium-3 increased membrane-
bound CHT1 in synaptosomal preparations (Rylett et al, 1993).
A close association of membrane-bound CHT1 immunoreac-
tivity and cellular differentiation was noted both in keratinocytes
and HaCaT cells. HaCaT cells preserved the capacity to reconsti-
tute an epidermal tissue when grown as surface transplants on nude
mice (Breitkreutz et al, 1998; Schoop et al, 1999) and undergo the
process of differentiation also in culture (Fusenig and Boukamp,
1998). After 1 d in culture CHT1 immunoreactivity was localized
intracellularly in cell islets while it shifted to a membrane
localization with the onset of the formation of a monolayer after
2 d of culture. Accordingly, membranous CHT1 immunolabeling
increased with differentiation of keratinocytes in situ along the
epidermal layers reaching a maximum before transition into dead
corneocytes. This process includes apoptotic secretion that is
regulated by cholinergic signaling (Nguyen et al, 2001). Similarly,
CHT1 immunoreactivity was prominent in a ring in the internal
root sheath, which corresponds in location to the so-called ``upper
ring'' where the cells switch to terminal differentiation followed by
exfoliation in the pilary canal (Barajon et al, 2001). Collectively,
these data are in favor of a crucial involvement of CHT1 in the
cholinergic signaling pathways regulating keratinocyte differenti-
ation processes.
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